Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group

Low rates of adult patient participation have been a persistent problem in cancer clinical trials and have continued to be a barrier to efficient drug development. The routine use of significant exclusion criteria has contributed to this problem by limiting participation in studies and creating sign...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical lung cancer 2020-07, Vol.21 (4), p.295-307
Hauptverfasser:	Forde, Patrick M., Bonomi, Phil, Shaw, Alice, Blumenthal, Gideon M., Ferris, Andrea, Patel, Chirag, Melemed, Allen, Basu Roy, Upal, Ramamoorthy, Anuradha, Liu, Qi, Burns, Timothy, Gainor, Justin F., Lovly, Christine, Piotrowska, Zofia, Lehman, Jonathan, Selig, Wendy
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer clinical trials Eligibility criteria Expanded access Non–small-cell lung cancer Small-cell lung cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!